They can determine the correct dosage, monitor you for any potential side effects, and adjust your protocol based on your bodys response
Your Klinic provider will collaborate with you to choose the best-suited option based on your health history, personal preferences, and insurance coverage
On the other end are some obesity specialists who view weight loss as the most important medical outcome
But it's mostly the produce, the meats and the dairies that I'm going for," she said
Neither Wegovy nor Ozempic, which also contains semaglutide but is licensed to help people with diabetes manage their blood sugar (it is frequently used off-label for weight loss), are approved for sale in India and Novos India Managing Director Vikrant Shrotriya told Reuters the company is planning to officially launch Wegovy in the country in 2026, admitting that it is difficult to trace illegal sellers in India